Spin-off and listing of Vistin Pharma (NO) on Oslo Axess — NOK 171 million

Spin-off and listing of Vistin Pharma (NO) on Oslo Axess — NOK 171 millionCarnegie acted as sole financial adviser in the spin-off and listing of Vistin Pharma. Vistin Pharma is a leading producer and supplier of active pharmaceutical ingredients (API), used in medications for diabetes and pain relief, and in cough medicine, and a contract manufacturer (CMO) of finished dose tablets. June 2015.